Eupraxia Pharmaceuticals Inc.
EPRXF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $133 | $70 | $41 | $46 |
| - Cash | $26 | $25 | $21 | $0 |
| + Debt | $14 | $11 | $10 | $13 |
| Enterprise Value | $121 | $56 | $30 | $58 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$37 | -$22 | -$21 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$38 | -$23 | -$23 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.58 | -1.21 | -1.61 | -0.31 |
| % Growth | -30.6% | 24.8% | -419.4% | – |
| Operating Cash Flow | -$28 | -$19 | -$15 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$28 | -$19 | -$15 | -$0 |